Clicky

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A(002932)

Description: Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.


Keywords: Diabetes Blood Endocrine System Thyroid Critical Illness Medical Diagnosis Diagnostic Equipment Drug Metabolism Human Anatomy Blood Gas Glands Molecular Diagnostic Products

Home Page: www.mdeasydiagnosis.com

Wuhan Optics Valley International Biomed
Wuhan,
China
Phone: 86 27 8700 1772


Officers

Name Title
Ms. Chen Li Li Chairman and Gen. Mang.
Mr. Zhao Ying Wen Chairman of the Supervisory Board and Quality Mang.
Ms. Wang Ying VP and Director
Mr. Zhou Yun Sec.

Exchange: SHE

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 2.1084
Price-to-Book MRQ: 1.6962
Price-to-Sales TTM: 1.2729
IPO Date:
Fiscal Year End: December
Full Time Employees: 1144
Back to stocks